CD8A and neoplasm: We further found that mouse or human tumors expressing low pERK are characterized by strong inflammation and enrichment of intratumoral CD8+ cytotoxic T cells expressing PD-1, an immune checkpoint receptor activated to promote tumor evasion from immune clearance [14–16].